Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Xi, Qing Zhang, K. Dyer, E. Lerner, T. Smithgall, W. Gooding, J. Kamens, J. Grandis (2003)
Src Kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck*Journal of Biological Chemistry, 278
T. Guren, John Ødegård, H. Abrahamsen, G. Thoresen, M. Šuša, Yvonne Andersson, Eva Østby, T. Christoffersen (2003)
EGF receptor‐mediated, c‐Src‐dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytesJournal of Cellular Physiology, 196
(2003)
STATs: Activation and Biology Sehgal PB, Levy DE and Hirano T (eds)
Pravin Sehgal, D. Levy, Toshio Hirano (2003)
Signal Transducers and Activators of Transcription (STATs)
T. Lund, Paul Prator, M. Medveczky, P. Medveczky (1999)
The Lck Binding Domain of Herpesvirus Saimiri Tip-484 Constitutively Activates Lck and STAT3 in T CellsJournal of Virology, 73
T. Kisseleva, S. Bhattacharya, J. Braunstein, C. Schindler (2002)
Signaling through the JAK/STAT pathway, recent advances and future challenges.Gene, 285 1-2
J. O’Shea, M. Gadina, R. Schreiber (2002)
Cytokine Signaling in 2002 New Surprises in the Jak/Stat PathwayCell, 109
D. Tice, J. Biscardi, Amanda Nickles, S. Parsons (1999)
Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.Proceedings of the National Academy of Sciences of the United States of America, 96 4
H. Chin, A. Arai, Hiroshi Wakao, Ryuichi Kamiyama, Nobuyuki Miyasaka, Osamu Miura (1998)
Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.Blood, 91 10
Tammy Bowman, R. Garcia, J. Turkson, R. Jove (2000)
STATs in oncogenesisOncogene, 19
CW Schindler, L Song (2003)
STATs: Activation and Biology
J. Odajima, I. Matsumura, J. Sonoyama, H. Daino, A. Kawasaki, Hirokazu Tanaka, N. Inohara, T. Kitamura, J. Downward, K. Nakajima, T. Hirano, Y. Kanakura (2000)
Full Oncogenic Activities of v-Src Are Mediated by Multiple Signaling PathwaysThe Journal of Biological Chemistry, 275
H. Seidel, P. Lamb, J. Rosen (2000)
Pharmaceutical intervention in the JAK/STAT signaling pathwayOncogene, 19
J. Biscardi, D. Tice, S. Parsons (1999)
c-Src, receptor tyrosine kinases, and human cancer.Advances in cancer research, 76
T. Lin, S. Mahajan, D. Frank (2000)
STAT signaling in the pathogenesis and treatment of leukemiasOncogene, 19
J. Biscardi, M. Maa, D. Tice, M. Cox, T. Leu, S. Parsons (1999)
c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function*The Journal of Biological Chemistry, 274
D. Levy, J. Darnell (2002)
Signalling: STATs: transcriptional control and biological impactNature Reviews Molecular Cell Biology, 3
A. Kazansky, E. Kabotyanski, S. Wyszomierski, M. Mancini, J. Rosen (1999)
Differential Effects of Prolactin andsrc/abl Kinases on the Nuclear Translocation of STAT5B and STAT5A*The Journal of Biological Chemistry, 274
Chao-Lan Yu, D. Meyer, G. Campbell, A. Larner, C. Carter-Su, J. Schwartz, R. Jove (1995)
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.Science, 269 5220
C. Gewinner, C. Mueller, M. Soler‐Lopez, B. Groner (2003)
Signal transducers and activators of transcription (STATs): Activation and Biology
Corinne Silva, J. Boerner, S. Parsons (2003)
Interactions of STATs with Src Family Kinases
T. Lund, R. Garcia, M. Medveczky, Richard Jove, P. Medveczky (1997)
Activation of STAT transcription factors by herpesvirus Saimiri Tip-484 requires p56lckJournal of Virology, 71
M. Kloth, A. Catling, Corinne Silva (2002)
Novel Activation of STAT5b in Response to Epidermal Growth Factor*The Journal of Biological Chemistry, 277
J. Biscardi, Allison Belsches, S. Parsons (1998)
Characterization of human epidermal growth factor receptor and c‐Src interactions in human breast tumor cellsMolecular Carcinogenesis, 21
S. Schreiner, A. Schiavone, T. Smithgall (2002)
Activation of STAT3 by the Src Family Kinase Hck Requires a Functional SH3 Domain*The Journal of Biological Chemistry, 277
M. Kloth, Kristen Laughlin, J. Biscardi, J. Boerner, S. Parsons, Corinne Silva (2003)
STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor*The Journal of Biological Chemistry, 278
J. Harris, M. Lippman, U. Veronesi, W. Willett (1992)
Breast cancer (Third of three parts)The New England Journal of Medicine, 327
Yi Zhang, J. Turkson, C. Carter-Su, T. Smithgall, A. Levitzki, A. Kraker, J. Krolewski, P. Medveczky, R. Jove (2000)
Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity*The Journal of Biological Chemistry, 275
Hua Yu, R. Jove (2004)
The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 4
E. Kabotyanski, J. Rosen (2003)
Signal Transduction Pathways Regulated by Prolactin and Src Result in Different Conformations of Activated Stat5b*The Journal of Biological Chemistry, 278
A. Brivanlou, J. Darnell (2002)
Signal Transduction and the Control of Gene ExpressionScience, 295
J. Sainsbury, A. Malcolm, D. Appleton, J. Farndon, A. Harris (1985)
Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.Journal of Clinical Pathology, 38
Z. Ren, T. Schaefer (2002)
ErbB-2 Activates Stat3α in a Src- and JAK2-dependent Manner*The Journal of Biological Chemistry, 277
Monilola Olayioye, Iwan Beuvink, K. Horsch, John Daly, N. Hynes (1999)
ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases*The Journal of Biological Chemistry, 274
R. Garcia, Tammy Bowman, G. Niu, Hua Yu, S. Minton, C. Muro-Cacho, C. Cox, R. Falcone, Rita Fairclough, S. Parsons, A. Laudano, A. Gazit, A. Levitzki, A. Kraker, R. Jove (2001)
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cellsOncogene, 20
The signal transducers and activators of transcription (STATs) were originally identified in the signaling pathway activated by the nontyrosine kinase containing cytokine receptors. The role of these STATs in hematopoietic cell signaling has been well described. In the case of cytokine receptors, activation of STAT tyrosine phosphorylation occurs through ligand-induced recruitment, and activation of the intracellular JAK kinases. However, STATs can also be activated by growth factor receptors, particularly the EGFR; as well as by members of the Src Family of Kinases (SFKs), particularly c-Src. In many cases, there is a differential activation of the STATs by these tyrosine kinases as compared to activation by the cytokine receptors. This difference provides for the potential of unique actions of STATs in response to growth factor receptor and SFK activation. Since there are many cancers in which SFKs and c-Src in particular, are co-overexpressed with growth factor receptors, it is not surprising that STATs play an important role in the tumorigenesis process induced by c-Src. The activation paradigm and role of STATs in these cancers, with particular emphasis on breast cancer models, is discussed.
Oncogene – Springer Journals
Published: Oct 18, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.